Full title:
CFS/ME, FM: “THERAPEUTIC TEST” AND FIRST TREATMENT SCHEME FOR PATIENTS WITH CHRONIC FATIGUE AND BRAIN FOG TO ASSIST THE DIAGNOSIS OF PERSISTENT CLOTS AND HYPOPERFUSION.
For patients with Chronic Fatigue Syndrome, Myalgic Encephalomyelitis,
Fibromyalgia, Persistent Symptoms of COVID, Chronic Lyme, Herpesvirus, EBV,
Bartonella, Babesia, Enterovirus, Coxsackievirus, HPV, Gulf War Disease,
Alzheimer's and, other Diseases that present Chronic Fatigue and Brain Fog.
Aguirre-Chang, Gustavo and Trujillo Aurora. ResearchGate. October 23, 2021.
https://www.researchgate.net/public...BiRGn3BZ8SYQuHiOXB_ueNUz-Cwv_cCYrCfom3Q565-Z4
BACKGROUND The symptoms of Chronic Fatigue and Brain Fog are associated more frequently with Endothelial Dysfunction and less Blood Flow. Chronic Fatigue Syndrome (CFS) affects many people, and often in addition to fatigue, patients present with various neurological symptoms known collectively as Brain Fog. Several studies have been published in which it is evidenced that, both in Chronic Fatigue Syndrome (CFS) and in the so-called Brain Fog, there is less blood flow and / or long-term dysfunction (inadequate functioning) at the level of the cells that make up the walls of blood vessels (endothelial cells and pericytes) [1-4].
Subgroup of CFS/ME associated with Endothelial Dysfunction and Persistent Clots. Our approach is that Chronic Fatigue Syndrome and Myalgic Encephalomyelitis (CFS/ME) include several Subgroups according to their pathophysiology and the causes that originate the symptoms, and most of the cases of CFS/ME correspond to a Subgroup in which there is an inadequate functioning of the blood vessels, more specifically a dysfunction of the endothelial cells, which in a high percentage is accompanied by a lower blood flow and a state of long-term hypercoagulability, with the presence of persistent clots that are attached to the vascular walls and also circulating intravascularly.
Other Subgroups of CFS/ME. There are other Subgroups within CFS/ME, such as that associated with Dysbiosis, SIBO or alteration of the Intestinal Microbiota, a situation in which D-Lactate is increased.
There are also Subgroups associated with Vitamin depletion (especially B complex) and Subgroups associated with decreased hormones (especially thyroid and adrenal). It should be taken into account that patients with CFS/ME can frequently present symptoms associated with several of the Subgroups of CFS/ME, being frequent that they present at the same time Endothelial Dysfunction, Dysbiosis or SIBO, and vitamin B complex depletion Endothelial dysfunction and persistent clots cause tissue hypoperfusion.
Long-term dysfunction of the blood vessel walls and the presence of persistent clots causes a decrease in the perfusion of fluids from the bloodstream to the cells and tissues, which is called tissue hypoperfusion, which implies a lower contribution to cells and tissues of:
- Oxygen (generating cellular hypoxia).
- Vitamins.
- Nutrients.
- Hormones. -
Other substances.
Long-term tissue hypoperfusion affects the normal functioning of organs and systems, especially those that require a greater supply of oxygen and nutrients, which are mainly the musculoskeletal system, the brain and the lungs.
Endothelial Dysfunction, Persistent Clots, and Hypoperfusion are not detectable with routine exams. The inadequate functioning of endothelial cells (endothelial dysfunction) and tissue hypoperfusion cause various organs and systems to not respond adequately when they are required, but it is a problem in the functioning that usually does not produce obvious tissue damage This is why most of the ancillary tests that are ordered routinely tend to be normal, such as X-rays, CT scans and routine laboratory tests.
Persistent Clots as a Cause of Hypoperfusion and Hypoxia. We have suggested that the main cause of tissue Hypoperfusion and cellular Hypoxia is due to the presence of persistent clots, which are characterized by having a high fibrin content [5,6]. On the one hand, adhered or fixed clots, as they are covering the wall of the blood vessels, create a layer or wall that reduces the perfusion of oxygen and substances from the blood to the tissues, and on the other hand, hypercoagulability and clots to Intravascular level they generate a slow blood flow which leads in the same way to a lower supply of oxygen, nutrients and other substances to the different tissues of the organism Persistent bioclots as a refuge for viruses and other microorganisms. We have also explained that viruses and other organisms that cause persistent intracellular infections take refuge in persistent clots that are high in fibrin [7,8,9,10]. Because these clots perform similar functions to Bioflims, we have named them Bioclots.
Further headings:
D-DIMER ANALYSIS FOR THE DIAGNOSIS OF PERSISTENT CLOTS.
MEASUREMENT OF VENOUS GASES AS AN AID TO THE DIAGNOSIS OF HYPOPERFUSION.
“THERAPEUTIC TEST” TO ASSIST THE DIAGNOSIS OF PERSISTENT BIOCOAGULES AND HYPOPERFUSION.
Objectives of the "Therapeutic Test" for Persistent Bioclots and Hypoperfusion.
MEDICATIONS AND SUPPLEMENTS INCLUDED IN THE "THERAPEUTIC TEST" FOR PERSISTENT BIOCLOTS AND HYPOPERFUSION.
CFS/ME, FM: “THERAPEUTIC TEST” AND FIRST TREATMENT SCHEME FOR PATIENTS WITH CHRONIC FATIGUE AND BRAIN FOG TO ASSIST THE DIAGNOSIS OF PERSISTENT CLOTS AND HYPOPERFUSION.
For patients with Chronic Fatigue Syndrome, Myalgic Encephalomyelitis,
Fibromyalgia, Persistent Symptoms of COVID, Chronic Lyme, Herpesvirus, EBV,
Bartonella, Babesia, Enterovirus, Coxsackievirus, HPV, Gulf War Disease,
Alzheimer's and, other Diseases that present Chronic Fatigue and Brain Fog.
Aguirre-Chang, Gustavo and Trujillo Aurora. ResearchGate. October 23, 2021.
https://www.researchgate.net/public...BiRGn3BZ8SYQuHiOXB_ueNUz-Cwv_cCYrCfom3Q565-Z4
BACKGROUND The symptoms of Chronic Fatigue and Brain Fog are associated more frequently with Endothelial Dysfunction and less Blood Flow. Chronic Fatigue Syndrome (CFS) affects many people, and often in addition to fatigue, patients present with various neurological symptoms known collectively as Brain Fog. Several studies have been published in which it is evidenced that, both in Chronic Fatigue Syndrome (CFS) and in the so-called Brain Fog, there is less blood flow and / or long-term dysfunction (inadequate functioning) at the level of the cells that make up the walls of blood vessels (endothelial cells and pericytes) [1-4].
Subgroup of CFS/ME associated with Endothelial Dysfunction and Persistent Clots. Our approach is that Chronic Fatigue Syndrome and Myalgic Encephalomyelitis (CFS/ME) include several Subgroups according to their pathophysiology and the causes that originate the symptoms, and most of the cases of CFS/ME correspond to a Subgroup in which there is an inadequate functioning of the blood vessels, more specifically a dysfunction of the endothelial cells, which in a high percentage is accompanied by a lower blood flow and a state of long-term hypercoagulability, with the presence of persistent clots that are attached to the vascular walls and also circulating intravascularly.
Other Subgroups of CFS/ME. There are other Subgroups within CFS/ME, such as that associated with Dysbiosis, SIBO or alteration of the Intestinal Microbiota, a situation in which D-Lactate is increased.
There are also Subgroups associated with Vitamin depletion (especially B complex) and Subgroups associated with decreased hormones (especially thyroid and adrenal). It should be taken into account that patients with CFS/ME can frequently present symptoms associated with several of the Subgroups of CFS/ME, being frequent that they present at the same time Endothelial Dysfunction, Dysbiosis or SIBO, and vitamin B complex depletion Endothelial dysfunction and persistent clots cause tissue hypoperfusion.
Long-term dysfunction of the blood vessel walls and the presence of persistent clots causes a decrease in the perfusion of fluids from the bloodstream to the cells and tissues, which is called tissue hypoperfusion, which implies a lower contribution to cells and tissues of:
- Oxygen (generating cellular hypoxia).
- Vitamins.
- Nutrients.
- Hormones. -
Other substances.
Long-term tissue hypoperfusion affects the normal functioning of organs and systems, especially those that require a greater supply of oxygen and nutrients, which are mainly the musculoskeletal system, the brain and the lungs.
Endothelial Dysfunction, Persistent Clots, and Hypoperfusion are not detectable with routine exams. The inadequate functioning of endothelial cells (endothelial dysfunction) and tissue hypoperfusion cause various organs and systems to not respond adequately when they are required, but it is a problem in the functioning that usually does not produce obvious tissue damage This is why most of the ancillary tests that are ordered routinely tend to be normal, such as X-rays, CT scans and routine laboratory tests.
Persistent Clots as a Cause of Hypoperfusion and Hypoxia. We have suggested that the main cause of tissue Hypoperfusion and cellular Hypoxia is due to the presence of persistent clots, which are characterized by having a high fibrin content [5,6]. On the one hand, adhered or fixed clots, as they are covering the wall of the blood vessels, create a layer or wall that reduces the perfusion of oxygen and substances from the blood to the tissues, and on the other hand, hypercoagulability and clots to Intravascular level they generate a slow blood flow which leads in the same way to a lower supply of oxygen, nutrients and other substances to the different tissues of the organism Persistent bioclots as a refuge for viruses and other microorganisms. We have also explained that viruses and other organisms that cause persistent intracellular infections take refuge in persistent clots that are high in fibrin [7,8,9,10]. Because these clots perform similar functions to Bioflims, we have named them Bioclots.
Further headings:
D-DIMER ANALYSIS FOR THE DIAGNOSIS OF PERSISTENT CLOTS.
MEASUREMENT OF VENOUS GASES AS AN AID TO THE DIAGNOSIS OF HYPOPERFUSION.
“THERAPEUTIC TEST” TO ASSIST THE DIAGNOSIS OF PERSISTENT BIOCOAGULES AND HYPOPERFUSION.
Objectives of the "Therapeutic Test" for Persistent Bioclots and Hypoperfusion.
MEDICATIONS AND SUPPLEMENTS INCLUDED IN THE "THERAPEUTIC TEST" FOR PERSISTENT BIOCLOTS AND HYPOPERFUSION.